Skip to main content
. 2020 Nov 5;5(1):bvaa171. doi: 10.1210/jendso/bvaa171

Figure 2.

Figure 2.

Dexcom G6 continuous glucose monitor tracings A, before, and B, after pasireotide addition, showing a reduction in glucose readings of less than 70 mg/dL from 48% to 8% of recorded values, respectively.